Analysts Trim Targets as Earnings Season Bites

Analyst target price cuts dominated activity on Sunday 25 October, with several large-cap names absorbing downgrades as earnings season sharpens expectations.

General Electric drew the most notable cut. The consensus target slipped to $378.90 from $382.81, a drop of nearly $4. GE Aerospace has been a strong performer in 2026, so even modest trimming stands out. The consensus sits at 20 buys, suggesting analysts remain broadly bullish but are recalibrating after recent price gains.

Abbott Laboratories also saw its average target trimmed, moving to $118.52 from $118.64. With 24 buy ratings and no sells, the direction of travel is positive. The cut was small but came from multiple brokers, pointing to measured caution ahead of its next print.

Bloom Energy attracted unusual attention. Multiple changes hit the stock in quick succession, including a recommendation removal. The consensus now shows two sells against 15 buys. The average target held near $284.

On the positive side, Merck received a target lift, moving to $159.76 from $158.56. Coinbase also gained, with its average target edging up to $213.55. SLB picked up an upgrade alongside a modest target improvement, reaching $62.34.

Honeywell saw its target trimmed to $253.48 from $255.09, part of a broader pattern of industrial names facing modest downward revisions this week. American Express followed the same path, its target slipping to $368.72 from $369.44.